Wednesday’s Pre-Market Look: Stocks In The News Before The Open
| | |

Wednesday’s Pre-Market Look: Stocks In The News Before The Open

Arrowhead Pharmaceuticals (ARWR) plunged 60% in after-hours trading after it said it will discontinue development of clinical stage drug candidates ARC-520, ARC-521 and ARC-AAT and will reduce its workforce by 30%. Nutanix — Nutanix (NTNX) lost 37 cents per share for its latest quarter, seven cents a share less than expected. The cloud data storage…

Tuesday Pre-Market Look: Stocks In The News Before The Open
| |

Tuesday Pre-Market Look: Stocks In The News Before The Open

Nivalis Therapeutics (NVLS) plunged over 50% in after-hours trading after it said its Phase 2 study evaluating cavosonstat failed to meet the primary endpoint in adult patients with cystic fibrosis. Pfizer (PFE) was upgraded to ‘Overweight’ from ‘Equalweight’ at Barclays with a 12-month price target of $38. Tiffany (TIF)— The luxury goods retailer earned 76…